Principal Financial Group
ENZ

Principal Financial Group’s Enzo Biochem, Inc. ENZ Stock Holding History

Principal Financial Group’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,447
Closed -$51K – 2320
2018
Q3 		$51K Buy
+12,447
New +$56.5K ﹤0.01% 2268
2018
Q2 		– Sell
-11,581
Closed -$63K – 2312
2018
Q1 		$63K Buy
11,581
+1,092
+10% +$7.69K ﹤0.01% 2172
2017
Q4 		$85K Buy
+10,489
New +$100K ﹤0.01% 2198
2014
Q4 		– Sell
-11,192
Closed -$58K – 2221
2014
Q3 		$58K Hold
11,192
– – ﹤0.01% 2178
2014
Q2 		$59K Buy
+11,192
New +$48.4K ﹤0.01% 2228

Other funds holding ENZ

EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group's ENZ Position: Q4 2018 in Review

Principal Financial Group sold out of Enzo Biochem, Inc. (ENZ) in Q4 2018, closing a stake of 12,447 shares — an estimated $51K sold.

Principal Financial Group first reported a position in ENZ in Q2 2014 and held it in 5 quarters. The position peaked at $85K in Q4 2017. 91 funds tracked by Wall St. Rank hold ENZ as of Q4 2018.

  • Principal Financial Group reported no remaining Enzo Biochem, Inc. position as of Q4 2018 after selling out during the quarter.
  • Principal Financial Group sold 12,447 Enzo Biochem, Inc. shares in Q4 2018, an estimated $51K.
  • Principal Financial Group first reported a position in Enzo Biochem, Inc. in Q2 2014 and held it in 5 quarters.
  • Principal Financial Group's Enzo Biochem, Inc. position peaked at $85K in Q4 2017.
  • 91 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2018.

Based on Principal Financial Group's 13F filing for Q4 2018, filed 14 Feb 2019.